Comparison of the activation status of tumor infiltrating and peripheral lymphocytes of patients with adenocarcinomas and benign hryperplasia of the prostate

Prostate

Volumn 45, Issue 1, 2000, Pages 1-7

  Elsässer Beile, Ursula ^a   Przytulski, Boris ^a   Gierschner, Dorothee ^a   Grussenmeyer, Thomas ^a   Katzenwadel, Arndt ^a   Leiber, Christian ^a   Deckart, Alexander ^a   Wetterauer, Ulrich ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Benign prostate hyperplasia; Cytokine expression; Prostate carcinoma; TIL

Indexed keywords

CD3 ANTIGEN; CYTOKINE; FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTIGENS, CD3; ANTIGENS, CD95; CYTOKINES; FAS LIGAND PROTEIN; GENE EXPRESSION; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RNA, MESSENGER;

EID: 0033848181     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20000915)45:1<1::AID-PROS1>3.0.CO;2-V     Document Type: Article

References (34)

1. Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma
2. An immunohistochemical characterisation of the inflammatory cell infiltrate in benign and malignant prostatic disease
3. Incidental lymphocytic prostatitis. Selective involvement with nonmalignant glands
4. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia
5. Cell-mediated cytotoxicity
6. The CTL's kiss of death
7. Evolution of the functional human -actin gene and its multipseudogene family: Conservation of noncoding regions and chromosomal dispersion of pseudogenes
8. Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes
9. The Fas counterattack: Fas- mediated T cell killing by colon cancer cells expressing Fas ligand
10. + tumor- infiltrating lymphocytes in human renal cell carcinoma
11. Tumor- reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor
12. Functional properties of tumor- infiltrating and blood lymphocytes in patients with solid tumors: Effects of tumor cells and their supernatants on proliferative responses of lymphocytes
13. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions
14. Separation, phenotyping and limiting dilution analysis of T-lymphocytes infiltrating human solid tumors
15. Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: Isolation, characterization, and antitumor activity
16. Fas ligand mediates activation-induced cell death in human T lymphocytes
17. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
18. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
19. Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells
20. Cytokine gene transcription in renal cell carcinoma
21. Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal carcinoma
22. Characterisation of gamma delta T cells in renal cell carcinoma patients by polymerase chain reaction analysis of T cell receptor transcripts
23. Quantitative analysis of Th1, Th2 and TGF-betal cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients
24. Selective expression of interleukin 10, interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies
25. Tumor- host interaction: Analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas
26. IL-10 production in cutaneous basal and squamous cell carcinomas: A mechanism for evading the local T cell immune response
27. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes
28. +- renal cell carcinoma infiltrating lymphocytes
29. Characterization of tumorin-filtrating lymphocyte subsets from human renal cell carcinoma-specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation
30. Tumor-specific cytokine release by donor T cells induces an effective host anti-tumor response through recruitment of host naive antigen presenting cells
31. Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes
32. In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen [see comments]
33. Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen
34. Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide